Edwards Lifesciences to be Added to the S&P 500 Index
IRVINE, CA - March 25, 2011 - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that Standard & Poor's (S&P) will add Edwards to the S&P 500 Index after the close of trading on Thursday, March 31, 2011.
"We are honored to be added to the S&P 500 Index. We attribute this milestone to the company's solid performance, resulting from the hard work of our employees in the development of innovative medical technologies for patients," said Thomas M. Abate, Edwards' corporate vice president, chief financial officer.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.
Media Contact:
Amanda C. Fowler
949-250-5070
Investor Contact:
David K. Erickson
949-250-6826
